AU2014212194A1 - Blood collection devices containing contact pathway inhibition additives - Google Patents

Blood collection devices containing contact pathway inhibition additives Download PDF

Info

Publication number
AU2014212194A1
AU2014212194A1 AU2014212194A AU2014212194A AU2014212194A1 AU 2014212194 A1 AU2014212194 A1 AU 2014212194A1 AU 2014212194 A AU2014212194 A AU 2014212194A AU 2014212194 A AU2014212194 A AU 2014212194A AU 2014212194 A1 AU2014212194 A1 AU 2014212194A1
Authority
AU
Australia
Prior art keywords
inhibitor
factor
blood
additive
kallikrein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2014212194A
Other languages
English (en)
Inventor
Keith A. Moskowitz
Frank L. Sinquett
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Becton Dickinson and Co
Original Assignee
Becton Dickinson and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Becton Dickinson and Co filed Critical Becton Dickinson and Co
Publication of AU2014212194A1 publication Critical patent/AU2014212194A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10—Preservation of living parts
    • A01N1/12—Chemical aspects of preservation
    • A01N1/122—Preservation or perfusion media
    • A01N1/126—Physiologically active agents, e.g. antioxidants or nutrients
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10—Preservation of living parts
    • A01N1/14—Mechanical aspects of preservation; Apparatus or containers therefor
    • A01N1/146—Non-refrigerated containers specially adapted for transporting or storing living parts whilst preserving
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
    • B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
    • B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
    • B01L3/5021—Test tubes specially adapted for centrifugation purposes
    • B01L3/50215—Test tubes specially adapted for centrifugation purposes using a float to separate phases
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
    • A61J1/06—Ampoules or carpules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/1406—Septums, pierceable membranes
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2300/00—Additional constructional details
    • B01L2300/04—Closures and closing means
    • B01L2300/041—Connecting closures to device or container
    • B01L2300/042—Caps; Plugs
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2300/00—Additional constructional details
    • B01L2300/04—Closures and closing means
    • B01L2300/041—Connecting closures to device or container
    • B01L2300/044—Connecting closures to device or container pierceable, e.g. films, membranes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Urology & Nephrology (AREA)
  • Environmental Sciences (AREA)
  • Biomedical Technology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Dentistry (AREA)
  • Molecular Biology (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Clinical Laboratory Science (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Physiology (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Materials For Medical Uses (AREA)
AU2014212194A 2013-02-01 2014-01-31 Blood collection devices containing contact pathway inhibition additives Abandoned AU2014212194A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361759742P 2013-02-01 2013-02-01
US61/759,742 2013-02-01
PCT/US2014/014089 WO2014121041A1 (en) 2013-02-01 2014-01-31 Blood collection devices containing contact pathway inhibition additives

Publications (1)

Publication Number Publication Date
AU2014212194A1 true AU2014212194A1 (en) 2015-09-17

Family

ID=51259520

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2014212194A Abandoned AU2014212194A1 (en) 2013-02-01 2014-01-31 Blood collection devices containing contact pathway inhibition additives

Country Status (12)

Country Link
US (1) US20140220552A1 (https=)
EP (1) EP2950718A4 (https=)
JP (1) JP2016505159A (https=)
KR (1) KR20150141940A (https=)
CN (1) CN105188535A (https=)
AU (1) AU2014212194A1 (https=)
BR (1) BR112015018077A2 (https=)
CA (1) CA2899594A1 (https=)
MX (1) MX2015009914A (https=)
RU (1) RU2015136025A (https=)
SG (1) SG11201505978PA (https=)
WO (1) WO2014121041A1 (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014113712A1 (en) 2013-01-20 2014-07-24 Dyax Corp. Evaluation and treatment of bradykinin-mediated disorders
JP6757252B2 (ja) 2013-10-21 2020-09-16 ダイアックス コーポレーション 血漿カリクレイン系バイオマーカーを決定するためのアッセイ
CA2927695C (en) 2013-10-21 2022-03-01 Dyax Corp. Diagnosis and treatment of autoimmune diseases
CN107567306B (zh) * 2015-05-14 2020-06-26 通用电气公司 用于血浆的分离和收集的装置
ES2938089T3 (es) 2015-08-13 2023-04-04 Takeda Pharmaceuticals Co Tubos de extracción de sangre al vacío que contienen inhibidores de proteasa para la evaluación de la activación del sistema de contacto
KR20240133761A (ko) 2015-10-19 2024-09-04 다케다 파머수티컬 컴패니 리미티드 절단된 고분자량 키니노겐의 검출을 위한 면역검정법
JP6844890B2 (ja) * 2016-01-07 2021-03-17 藤森工業株式会社 採血管、試薬及びそれらを利用した血液性状分析方法
CN108342381A (zh) * 2017-01-24 2018-07-31 梁建国 一种用于稳定保存外周血中循环游离dna的溶剂
US11672733B2 (en) * 2017-07-21 2023-06-13 Amgen Inc. Gas permeable sealing member for drug container and methods of assembly
US12485412B2 (en) * 2021-08-05 2025-12-02 Lance Liberti Kit including biotin for harvesting platelet-rich plasma
CN115555070B (zh) * 2022-10-18 2024-11-05 北京积水潭医院 一种prf离心管
GB202219505D0 (en) * 2022-12-22 2023-02-08 Turzi Antoine Medical composition

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1084270B1 (en) * 1998-06-08 2004-08-25 The University Of Vermont And State Agricultural College Methods for assaying clotting in plasma
US20030064414A1 (en) * 2001-03-30 2003-04-03 Benecky Michael J. Rapid assessment of coagulation activity in whole blood
AU2003234382B2 (en) * 2002-05-13 2010-07-08 Becton, Dickinson And Company Protease inhibitor sample collection system
US8603345B2 (en) * 2003-02-13 2013-12-10 Becton, Dickinson And Company Devices for component removal during blood collection, and uses thereof
US7235377B2 (en) * 2003-06-09 2007-06-26 The University Of Vermont And State Agriculture College Global test of the hemostatic system
GB0711779D0 (en) * 2007-06-18 2007-07-25 Univ Singapore Thrombin inhibitor
PT3002298T (pt) * 2007-11-21 2019-11-20 Univ Oregon Health & Science Anticorpos monoclonais anti-fator xi e métodos de utilização dos mesmos
US10299714B2 (en) * 2010-12-02 2019-05-28 Becton, Dickinson And Company Blood collection devices containing blood stabilization agent including variegin or analog thereof and/or a polysulfated disaccharide
CN103415301A (zh) * 2011-03-09 2013-11-27 德国杰特贝林生物制品有限公司 用于与包括与人造表面接触的医疗操作一起施用的fxii抑制剂

Also Published As

Publication number Publication date
BR112015018077A2 (pt) 2017-07-18
US20140220552A1 (en) 2014-08-07
RU2015136025A (ru) 2017-03-06
MX2015009914A (es) 2015-09-25
EP2950718A1 (en) 2015-12-09
SG11201505978PA (en) 2015-08-28
JP2016505159A (ja) 2016-02-18
EP2950718A4 (en) 2016-09-21
KR20150141940A (ko) 2015-12-21
WO2014121041A1 (en) 2014-08-07
CA2899594A1 (en) 2014-08-07
CN105188535A (zh) 2015-12-23

Similar Documents

Publication Publication Date Title
US20140220552A1 (en) Blood collection devices containing contact pathway inhibition additives
JP5937612B2 (ja) 血液安定剤を含む採血用デバイス
EP3002591B1 (en) Composition for the determination of coagulation characteristics of a test liquid
AU2012279135B2 (en) Coagulation controlling agents and devices comprising the same
MXPA04011129A (es) Sistema de recoleccion de muestra de inhibidor de proteasa.
Kobsar et al. Composition of plasma in apheresis-derived platelet concentrates under cold storage
Harbaugh et al. Antithrombin and antithromboplastin activity accompanying IgG myeloma: Report of a case with a severe bleeding tendency
NZ619674B2 (en) Coagulation controlling agents and devices comprising the same

Legal Events

Date Code Title Description
MK4 Application lapsed section 142(2)(d) - no continuation fee paid for the application